1. Home
  2. IMTX vs NAGE Comparison

IMTX vs NAGE Comparison

Compare IMTX & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMTX
  • NAGE
  • Stock Information
  • Founded
  • IMTX N/A
  • NAGE 1999
  • Country
  • IMTX Germany
  • NAGE United States
  • Employees
  • IMTX N/A
  • NAGE N/A
  • Industry
  • IMTX Biotechnology: Biological Products (No Diagnostic Substances)
  • NAGE Medicinal Chemicals and Botanical Products
  • Sector
  • IMTX Health Care
  • NAGE Health Care
  • Exchange
  • IMTX Nasdaq
  • NAGE Nasdaq
  • Market Cap
  • IMTX 579.8M
  • NAGE 594.0M
  • IPO Year
  • IMTX N/A
  • NAGE N/A
  • Fundamental
  • Price
  • IMTX $4.24
  • NAGE $8.95
  • Analyst Decision
  • IMTX Strong Buy
  • NAGE Strong Buy
  • Analyst Count
  • IMTX 4
  • NAGE 1
  • Target Price
  • IMTX $16.67
  • NAGE $11.00
  • AVG Volume (30 Days)
  • IMTX 426.9K
  • NAGE 821.9K
  • Earning Date
  • IMTX 05-20-2025
  • NAGE 05-07-2025
  • Dividend Yield
  • IMTX N/A
  • NAGE N/A
  • EPS Growth
  • IMTX N/A
  • NAGE N/A
  • EPS
  • IMTX 0.14
  • NAGE 0.18
  • Revenue
  • IMTX $161,336,577.00
  • NAGE $107,925,000.00
  • Revenue This Year
  • IMTX N/A
  • NAGE $21.53
  • Revenue Next Year
  • IMTX $4.92
  • NAGE $20.87
  • P/E Ratio
  • IMTX $29.25
  • NAGE $50.01
  • Revenue Growth
  • IMTX 188.60
  • NAGE 29.77
  • 52 Week Low
  • IMTX $3.30
  • NAGE $2.31
  • 52 Week High
  • IMTX $13.77
  • NAGE $9.50
  • Technical
  • Relative Strength Index (RSI)
  • IMTX 43.11
  • NAGE N/A
  • Support Level
  • IMTX $3.94
  • NAGE N/A
  • Resistance Level
  • IMTX $5.41
  • NAGE N/A
  • Average True Range (ATR)
  • IMTX 0.35
  • NAGE 0.00
  • MACD
  • IMTX -0.04
  • NAGE 0.00
  • Stochastic Oscillator
  • IMTX 20.41
  • NAGE 0.00

About IMTX Immatics N.V.

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Share on Social Networks: